In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhi, Li ^a   Chi, Xuan ^a   Vostal, Jaroslav G ^a  

^a Division of Hematology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 BETA3 INTEGRIN; LYMPHOCYTE ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG INJURY; LUNG LAVAGE; MOUSE; NONHUMAN; PLEURA CAVITY; PROTEIN SECRETION; RADIATION EXPOSURE; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; ULTRAVIOLET C RADIATION;

ACUTE LUNG INJURY; ANIMALS; BLOOD PLATELETS; FEMALE; HUMANS; LUNG; MICE; MICE, SCID; PLATELET TRANSFUSION; ULTRAVIOLET RAYS;

EID: 84891476795     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079869     Document Type: Article

References (34)

1. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS et al. (2003) Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program: 575-589.
2. Montag T (2008) Strategies of bacteria screening in cellular blood components. Clin Chem Lab Med 46: 926-932. PubMed: 18624615.
3. Council of Europe (2002) Guide to the preparation, use and quality assurance of blood components, 8th ed. Strasbourg: Council of Europe Publishing.
4. Lockwood WB, Leonard J, Liles S Chapter 9: Storage, Monitoring, Pretransfusion Processing, and Distribution of Blood Components. Technical Manual, 16th ed. AABB.
5. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS et al. (2009) Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 49 (Suppl 2): 1S-29S. doi:10.1111/j.1537-2995.2009.02279.x. PubMed: 19686562.
6. Irsch J, Lin L (2011) Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System. Transfus Med Hemother 38: 19-31. doi:10.1159/000323937. PubMed: 21779203.
7. Marschner S, Goodrich R (2011) Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light. Transfus Med Hemother 38: 8-18. doi:10.1159/000324160. PubMed: 21779202.
8. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J et al. (2008) Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 22: 133-153. doi:10.1016/j.tmrv.2007. 12.003. PubMed: 18353253.
9. Ciaravino V, McCullough T, Cimino G, Sullivan T (2003) Preclinical safety profile of plasma prepared using the INTERCEPT Blood System. Vox Sang 85: 171-182. doi:10.1046/j.1423-0410.2003.00351.x. PubMed: 14516447.
10. Teitel JM (2000) Viral safety of haemophilia treatment products. Ann Med 32: 485-492. doi:10.3109/07853890009002024. PubMed: 11087169.
11. Seltsam A, Müller TH (2011) UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma. Transfus Med Hemother 38: 43-54. doi:10.1159/000323845. PubMed: 21779205.
12. Mohr H, Steil L, Gravemann U, Thiele T, Hammer E et al. (2009) A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light. Transfusion 49: 2612-2624. doi:10.1111/j.1537-2995.2009. 02334.x. PubMed: 19682340.
13. Harm W (1980) Biology effects of ultraviolet radiation. Cambridge: Cambridge, UK.
14. Picker SM, Schneider V, Oustianskaia L, Gathof BS (2009) Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 49: 2311-2318. doi:10.1111/j.1537- 2995.2009.02316.x. PubMed: 19624608.
15. Bashir S, Cookson P, Wiltshire M, Hawkins L, Sonoda L et al. (2012) Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets. Transfusion 53: 990-1000. PubMed: 22905813.
16. Snyder E, Raife T, Lin L, Cimino G, Metzel P et al. (2004) Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light. Transfusion 44: 1732-1740. doi:10.1111/j.0041-1132.2004.04145.x. PubMed: 15584988.
17. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P et al. (2005) Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 45: 1335-1341. doi:10.1111/j.1537-2995.2005. 00202.x. PubMed: 16078923.
18. Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I et al. (2005) Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial. Transfusion 45: 1864-1875. doi:10.1111/j.1537-2995.2005.00639.x. PubMed: 16371039.
19. Cazenave JP, Follea G, Bardiaux L, Boiron JM, Lafeuillade B et al. (2010) A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 50: 2362-2375. doi:10.1111/j.1537-2995.2010.02694.x. PubMed: 20492615.
20. Gelderman MP, Chi X, Zhi L, Vostal JG (2011) Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion. Transfusion 51: 2343-2357. doi:10.1111/j.1537-2995.2011.03135.x. PubMed: 21492179.
21. Zhi L, Chi X, Gelderman MP, Vostal JG (2012) Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model. Transfusion.
22. Chi X, Zhi L, Gelderman MP, Vostal JG (2012) Host platelets and, in part, neutrophils mediate lung accumulation of transfused UVB-irradiated human platelets in a mouse model of acute lung injury. PLOS ONE 7: e44829. doi:10.1371/journal.pone.0044829. PubMed: 23028636.
23. Kirkeby S, Thomsen CE (2005) Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J Immunol Methods 301: 102-113. doi:10.1016/j.jim.2005.04.006. PubMed: 15982663.
24. Verhaar R, Dekkers DW, De Cuyper IM, Ginsberg MH, de Korte D et al. (2008) UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood 112: 4935-4939. doi:10.1182/blood- 2008-04-151043. PubMed: 18796633.
25. Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated plaelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70: 307-315. PubMed: 3297204.
26. Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in te platelet membrane glycoprotin IIb-IIIa complex during platelet activation. J Biol Chem 260: 11107-11114. PubMed: 2411729.
27. Taub R, Gould RJ, Garsky VM, Ciccarone TM, Hoxie J et al. (1989) A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 264: 259-265. PubMed: 2909518.
28. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG et al. (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33: 721-726. doi:10.1097/01.CCM.0000159849.94750.51. PubMed: 15818095.
29. Sandgren P, Tolksdorf F, Struff WG, Gulliksson H (2011) In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method. Vox Sang 101: 35-43. doi:10.1111/j.1423-0410.2010.01454.x. PubMed: 21175668.
30. Lasky LA (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258: 964-969. doi:10.1126/science. 1439808. PubMed: 1439808.
31. Shattil SJ, Kim C, Ginsberg MH (2010) The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 11: 288-300. doi:10.1038/nrm2871. PubMed: 20308986.
32. Bassler N, Loeffler C, Mangin P, Yuan Y, Schwarz M et al. (2007) A mechanistic model for paradoxical platelet activation by ligand-mimetic alphaIIb beta3 (GPIIb/IIIa) antagonists. Arterioscler Thromb Vasc Biol 27: e9-15. doi:10.1161/01.ATV.0000255307.65939.59. PubMed: 17170374.
33. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH (2000) Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS). Circulation 102: 624-629. doi:10.1161/01.CIR.102.6.624. PubMed: 10931801.
34. Merten M, Thiagarajan P (2000) P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102: 1931-1936. doi:10.1161/01.CIR.102.16.1931. PubMed: 11034941.